35 / 220
基準劑量推估每日可接受攝食量
33
Pesticide Sex Endpoint
BM
4)
AIC SR
5)
P BMD BMDL
BMD/
BMDL
RN
6)
NA Squamous
cell carci-
noma
M 59 0.02 0.20 10
5
2
NA Hepatocel-
lular fatty
change
LL 249 -0.66 0.40 1.89 0.86 2.2
NA Hepatocel-
lular fatty
change
LL 202 0
0.35 25
3.2
7.81
NA Adenoma
+carcinoma
LL 438 -0.35 0.08 268
46
5.83
NA Adenoma
+carcinoma
Lc 268 -0.23 0.59 120
99
1.21
NA Hepatocel-
lular hyper-
trophy
LL 233 -0.62 0.38 6.0
3.18 1.89
NA Hepatocel-
lular hyper-
trophy
G 241 -0.02 0.97 3.02 2.77 1.09
NA Liver foci
alteration
LL 335 -0.86 0.13 1.55 0.99 1.57
NA Bladder
papillomas
carcinoma
G 78 0.19 0.94 19
13
1.46
NA Bladder
papillomas
carcinoma
G 112 -0.84 0.13 33
25
1.32
NA Testicular
tumor
LL 191 0
0.34 28
13
2.15
NA Cleft palate G 36 0
1
171
50
3.42
NA Absence of
renal papilla
G 37 0
1
163
50
3.26
表一、分析
31
種農藥之基準劑量與其最適模式、相關參數及資料來源（續）
Table 1.
Parameters and source of BMD analysis for the 31 pesticide risk assessment models
(continued)